O-linked N-acetylglucosamine (O-GlcNAc) is an abundant posttranslationally modified compound in eukaryotic cells. Human O-GlcNAc transferase (OGT) was produced as a maltose binding protein (MBP) fusion protein, which showed significant catalytic activity to modify recombinant Sp1, transcription factor. To facilitate the production of O-GlcNAc modified proteins, instead of using the tedious in vitro glycosylation reaction or expression in eukaryotic cells, a MBP-fusion OGT expression vector (pACYC 184-MBPOGT) was constructed using pACYC 184 plasmid, which could coexist with general prokaryotic expression vectors containing ColE 1 origin. By cotransforming pACYC184-MBPOGT and pGEX-2T vectors into Escherichia coli BL21, intracellular O-GlcNAcylated proteins could be obtained by a simple purification procedure. It is expected that this may be a useful tool for production of O-GlcNAc modified proteins.
机构:
Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA